Kalaris Therapeutics (KLRS) Return on Equity (2020)
Kalaris Therapeutics (KLRS) has 1 years of Return on Equity data on record, last reported at 0.36% in Q3 2020.
Kalaris Therapeutics (KLRS) has 1 years of Return on Equity data on record, last reported at 0.36% in Q3 2020.